Fusion Antibodies plc (FAB.L) LSE

14.50

+0.75(+5.45%)

Updated at December 04 06:36PM

Currency In GBp

Valuation

Market Cap5.9M
Enterprise Value5.56M
P/E Ratio-8.16
PEG Ratio-0.35
Price/Sales Ratio8.39
Price/Book Ratio20.89
Enterprise/Revenue8.21
Enterprise/EBITDA-9.94

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.87
Operating Margin-0.91

Management Effectiveness

Return On Assets-1.29
Return On Equity-1.98

Income Statement

Revenue1.97M
Revenue/Share0.02
Gross Profit430,000
EBITDA-1.62M
Net Income-1.71M
Diluted EPS-0.02

Balance Sheet

Total Cash359,000
Total Cash/Share0
Total Debt20,000
Total Debt/Equity0.03
Current Ratio2.02
Book Value Per Share0.01

Price History

52-Week Change147.86
52-Week High21
52-Week Low5.06
Moving Average 50 Days13.85
Moving Average 200 Days10.19

Statistics

Average Volume1M
Shares Outstanding113.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A